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Background: Congenital hemangiomas are benign abnormal proliferation of blood vessels. Noninvoluting
congenital hemangiomas are a rare variant which persist, and may become bigger. Hemangiomas are known to be
associated with thrombocytopenia, microangiopathic hemolytic anemia and Kasabach-Merritt phenomenon.
Kasabach-Merritt phenomenon is characterized by consumptive coagulopathy with microangiopathic haemolyic
anemia and thrombocytopenia. Platelet sequestration in the hemangioma or increased destruction which may
either be immune or non immune are also further contributors to thrombocytopenia.
Case presentation: A 45 year old female with a non involuting hemangioma and baseline thrombocytopenia was
observed to develop repeated episodes of transient severe thrombocytopenia associated with a variety of infectious
conditions. Laboratory investigations suggested a peripheral mechanism. Platelet counts always returned to
baseline levels on resolution of the precipitating infection.
Conclusion: The authors report this phenomenon as the first reported case of baseline thrombocytopenia
complicated by recurrent episodes of transient severe thrombocytopenia following infections associated with a non
involuting congenital hemangioma. The observations made in this patient were unique and hitherto unreported in
medical literature. Both peripheral sequestration and destructive consumption were considered likely. Consumptive
mechanisms were likely to encompass either or both immune and non immune causes. Further studies are needed
to establish the precise pathogenesis.
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Congenital hemangiomas are benign abnormal proliferation
of blood vessels [1]. Noninvoluting congenital hemangi-
omas are a rare variant of cutaneous vascular tumors of
intrauterine onset which persist - either unchanged or with
slight enlargement [2]. Hemangioma-thrombocytopenia
syndrome associated with microangiopathic hemolytic
anemia has been documented in children. The Kasabach-
Merritt phenomenon was described first in 1940 as a* Correspondence: mcs627@gmail.com
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distribution, and reproduction in any mediumsyndrome of consumptive coagulopathy, in patients with
capillary hemangiomas characterized by microangiopathic
haemolyic anemia and thrombocytopenia [3]. Rapidly
involuting congenital haemangiomas are known to
be associated with fluctuating thrombocytopenia and
coagulopathy [4]. Thrombocytopenia is a complication
seen in adult patients with large or multiple hemangiomas
[5]. This phenomenon may occur due to sequestration in
the hemangioma or increased destruction which may be
due to either immune or non immune causes [6]. Chronic
immune thrombocytopenia is known to occur in infections
[7], and acute immune mediated thrombocytopeniatral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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Figure 1 Non involuting hemangioma with ulcerated areas.
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sitivity states [8-11]. Thrombocytopenia associated with
infections has been known to parallel the severity of illness
[12]. However literature search yielded no similar case
with baseline thrombocytopenia complicated by recurrent
episodes of transient severe thrombocytopenia following
infections in a patient with a non involuting congenital
hemangioma.
Case presentation
A 45 year old single woman with a non regressing
congenital vascular malformation of the right arm and
upper chest, presented with a 3 day history of high fever,
chills, dysuria, hematuria and right loin discomfort. Her
urine output was normal and she had no spontaneous
bleeding manifestations or features of uremia. A marked
drop in her platelet counts compared to recent baseline
levels had been detected by her primary care physician
following the onset of symptoms.
Her past medical history was significant for persistent
low baseline platelet counts in the region of 100,000/mm3
with episodic reduction to values as low as 30,000/mm3
following infections. She had been extensively and
repeatedly investigated from the time the low baselines
platelet counts were detected at the age of 28, however no
definite cause was identified. On direct questioning she
denied spontaneous mucocutaneous bleeding in the past.
However her past medical history was significant for an
abandoned plastic surgical procedure after developing a
haematoma surrounding the preoperative intravenous
cannulation site with a corresponding platelet count of
47,000/mm3. She had also been managed conservatively
for uterine adenomyosis with depot provera from the age
of 45 due to concerns of high risk of perioperative
bleeding.
Detailed evaluation was negative for symptoms attribut-
able to anemia, connective tissue disease and liver disease.
History of medications was negative for agents associated
with thrombocytopenia.
Examination revealed an ill looking lady with a
temperature of 100.4 degrees Fahrenheit. She had a giant
hemagioma involving the entire right arm, right lateral
aspect of the neck and both the anterior and posterior
aspect of the chest extending up to the 4th intercostal
space (Figure 1). The hemangioma had small areas which
were ulcerated and inflamed as well as healed scars. A soft
bruit was appreciated on auscultation over the hemangioma.
She had no petichiae or ecchymoses and her conjunctivae
were pink. No lymphadenopathy was detected.
Cardiovascular examination was remarkable only for a
pulse rate of 104/min. The blood pressure was 100/60 mm
Hg. Abdominal examination revealed mild right loin
tenderness without any organomegaly. Clinical pelvic
examination was not performed respecting the patient’swishes. Respiratory system and nervous system examination
were both unremarkable.
The urine full report demonstrated 15–20 pus cells
and 30–40 red cells per high powered field. Complete
blood count on admission showed a hemoglobin of 11 g/dl
with a neutrophil leukocytosis (WBC count of 17,000/
mm3 – neutrophils 88%, lymphocytes 10%). The platelet
count was 27,000/mm3. C reactive protein was elevated at
196 mg/dl (reference upper limit - 6 mg/dl). Serial
complete blood counts done on days 4 & 5 of the illness
revealed a progressive drop in platelet counts to a nadir of
15,000/mm3. Blood film showed severe thrombocytopenia
with toxic neutrophils. Schistocytes suggestive of micro-
angiopathic haemolytic anemia were notably absent. Her
serum creatinine was mildly elevated at 1.52 mg/dl
(reference upper limit - 1.3 mg/dl). Other biochemical
parameters including uric acid, electrolytes and liver
profile were all within normal limits. Both blood culture
and urine culture yielded gram negative Escherichia coli
with identical overlapping antibiotic sensitivity patterns.
The wound swab from the ulcerated areas of the
hemangioma became positive for Staphylococcus aureus
sensitive to both penicillin and cloxacillin. Dengue NS1
antigen was negative. Ultrasonic examination of the
abdomen excluded splenomegaly, features of portal
hypertension and chronic liver disease. HIV, ANA,
antiphospholipid antibodies, antiplatelet antibodies and
Coombs test were all negative.
Background consumptive coagulopathy was excluded
with normal baseline INR, APTT, D-dimers by modified
ELISA and fibrinogen levels. There was also no laboratory
evidence of acute derangement of the coagulation profile
in relation to the worsening of thrombocytopenias
triggered by infections.
In depth perusal of her previous admission records
confirmed repeated episodes of severe thrombocytopenia
(<30,000/mm3) precipitated with a variety of infections with
return to baseline values of approximately 100,000/mm3 on
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investigations no cause or basis had ever been identified
in her to explain the phenomenon. The last episode of
severe thrombocytopenia was triggered by an upper re-
spiratory tract infection which had occurred 4 months





13 February 2002 85 Baseline
20 May 2003 75 Baseline
01 September 2003 50 Respiratory tract infection
08 September 2003 47 Surgery abandoned – Cannula
site bleed
10 October 2003 22 Fever- Source / Cause? Viral
10 February 2004 33 Gasteroenteritis
20 February 2004 88 Convalescent
03 March 2006 123 Baseline
01 July 2006 23 Tonsillitis
11 July 2006 86 Baseline
14 July 2006 78 Baseline
07 August 2006 171 Baseline
25 November 2006 38 Viral fever
01 December 2006 88 Convalescent
26 December 2006 86 Baseline
23 January 2007 134 Baseline
01 December 2007 24 Otitis media
22 December 2007 88 Baseline
10 April 2009 22 Skin sepsis
14 April 2009 71 Convalescent
27 April 2009 143 Baseline
08 August 2010 52 Skin sepsis
12 August 2010 72 Baseline
19 August 2010 90 Baseline
02 May 2011 130 Baseline
02 July 2012 48 Upper respiratory tract infection
03 July 2012 46 Upper respiratory tract infection
04 July 2012 60 Upper respiratory tract infection
10 August 2012 92 Baseline
01 October 2012 61 Urinary & skin sepsis
02 October 2012 27 Urinary & skin sepsis
03 October 2012 15 Urinary & skin sepsis
06 October 2012 68 Urinary & skin sepsis
07 October 2012 78 Convalescent
14 October 2012 101 Baselineinfections and wound sepsis complicating ulcerated
areas over the hemangioma were the commonest pre-
cipitants identified.
Bone marrow studies done during a recent episode of
severe thrombocytopenia had demonstrated a normal
marrow including megakaryopoiesis, whilst the peripheral
blood smear had shown evidence of thrombocytopenia
and toxic left shift in the neutrophils which were con-
sidered to be consistent with a peripheral cause for
thrombocytopenia on a background of ongoing infection.
Repeated therapeutic trials with steroids had shown no
improvement in the thrombocytopenia during episodes of
infection and a rise in platelet counts was always tempor-
ally related to the resolution of the infection rather than
steroid therapy. The baseline thrombocytopenias were not
severe enough to warrant continued steroid therapy.
However the episodic thrombocytopenias with infections
had initially been treated with steroids. Platlet count trends
during infections showed that the thrombocytopenia
seemed to improve with the resolution of the causative
infection rather than steroids. This was observed on many
occasions in the patient and after the initial few trials no
further steroid therapy was attempted. Thrombocytopenia
was seen even on several occasions where the patient
presented with untreated infections where she had neither
been prescribed or used any medications and hence a drug
induced cause was deemed unlikely. Acetaminophen was
used by the patient unrelated to infections as an analgesic
especially in relation to painful menstruation and no
alteration in baseline platelet counts attributable to
acetaminophen were seen.
Her current illnesswas treated with a combination of
intravenous levofloxacin and clindamycin which resulted in
complete defervescence by the 3rd day of hospitalisation.
When she was discharged on the 3rd day post admission,
her platelet counts had risen to 79,000/mm3 with im-
provement in serum creatinine to 1.2 mg/dl and the urine
full report was free of any evidence of persistent urinary
sepsis. She was discharged on oral co amoxiclav and
clindamycin for a further period of one week and advised
to continue oral penicillin indefinitely to prevent wound
sepsis.
Discussion
Congenital hemangiomas are benign abnormal proliferation
of blood vessels [1]. Hemangiomas arise from mesenchymal
tissue composed of multiple vascular channels lined with
a single layer of endothelium on a scaffolding of fibrous
connective tissuewhich frequently proliferate early in life
before regressing in size. Vascular malformations despite
many similarities in architecture to hemangiomas, differ
by the presence of dysplastic endothelium and lack of
regression. Congenital hemangiomas despite being present
at birth often become clinically evident only later. Vascular
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most closely resemble namely capillary, venous, and lymph-
atic [13]. Rapidly involuting (RICH) and non-involuting
(NICH) “congenital” hemangiomas appear to be histo-
pathological hybrids showing features of both vascular
tumor and malformation, and both entities are believed to
lie within the same spectrum [14].
Noninvoluting congenital hemangiomas are rare variants
of cutaneous vascular tumors of intrauterine onset with-
out sex prevalence and they are described as well-
circumscribed, plaque-like or slightly bossed lesions
which never disappear and persist either unchanged or
with slight expansion [2].
In a case series by Jin et al. magnetic resonance imaging,
computed tomographic angiography and digital subtraction
angiography of non involuting congenital hemangioma
gave findings similar to radiological findings of common
infantile hemangiomas [15].
The platelet count in adults ranges from 150,000
to 450,000/mm3, with mean values of 237,000 and
266,000/mm3 in males and females, respectively [16].
Thrombocytopenia is defined as a platelet count of less
than 150,000/mm3. Thrombocytopenia may be caused by
increased peripheral destruction, sequestration or re-
duced production. A detailed description of the causes
thrombocytopenia is not within the scope of this case
report, as a multitude of causes including many states of
infection could be possible aetiologies [6].
Clinical observation of repeated episodes of severe
thrombocytopenia during a succession of varieties of
infections temporally establishes the relationship between
the phenomenon of severe thrombocytopenia and infec-
tions in this patient The authors excluded common and
likely alternative causes of thrombocytopenia in the subject
including dengue fever, drugs, portal hypertension and
marrow pathologies and therefore the phenomenon is
explained by either sequestration or increased destruction
within the hemangioma which may either be immune or
non immune [6]. This is further supported by the
combined findings of the blood film and bone marrow
trephine biopsy done during a similar episode in the
past which showed thrombocytopenia and normal
megakaryopoiesis respectively. The chronic thrombo-
cytopenia is likely due to due to chronic consumption
within the hemangioma. A baseline state of inflammation
within the hemangioma with aggravation due to infections
causing increased consumption could be postulated how-
ever demonstrating or disproving this requires molecular
and microscopic studies which are not feasible for ethical
reasons. Sequestration causing thrombocytopenia is also
unlikely as an explanation for the acute thrombocytopenia
with infection though such an explanation cannot be
discounted as the reason for the baseline state of low
platelets. Radiolabelled platelet tracer studies are notpossible in the clinical setting where the authors encoun-
tered the patient.
In patients without hemangiomas chronic immune
thrombocytopenia is known to occur in infections [7],
and acute immune mediated thrombocytopenia has been
demonstrated in certain infections and hypersensitivity
states [8-11]. Thrombocytopenia associated with infections
has been known to parallel the severity of illness [12]. It
was postulated that this patient who had a baseline
thrombocytopenia due to sequestration and destruction
within the hemangioma most likely developed super-
imposed immune mediated destruction of platelets triggered
by a variety of infective conditions.
Hemangioma-thrombocytopenia syndrome associated
with microangiopathic hemolytic anemia has been docu-
mented in children. The Kasabach-Merritt phenomenon
was first described in 1940 as a syndrome of consumptive
coagulopathy, with capillary hemangiomas having clearly
demonstrable microangiopathic haemolyic anemia and
thrombocytopenia [3]. Rapidly involuting congenital
haemangioma is known to be associated with transient
thrombocytopenia and coagulopathy [4]. Although throm-
bocytopenia has been documented in adult patients with
large or multiple hemangiomas s no reports were found in
literature documenting repeated episodes of severe throm-
bocytopenia triggered by a variety of successive infectious
conditions in a patient having a non involuting congenital
hemangioma with baseline thrombocytopenia.Conclusion
The authors report this case as a novel observation
and suggest that further studies are needed to establish
the phenomenon and pathogenesis in cohorts with
non involuting congenital hemangiomas.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the editor of this journal.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
All authors were involved in the clinical management of the patient,
literature survey and drafting of the manuscript. All authors read and
approved the final manuscript.
Author details
1National Hospital of Sri Lanka, Regent Street, Colombo 7, Sri Lanka. 2Lanka
Hospitals, Colombo 5, Sri Lanka. 3Faculty of Medicine, University of Sri
Jayawardenapura, Nugegoda, Sri Lanka.
Received: 18 October 2012 Accepted: 11 June 2013
Published: 13 June 2013
Shivanthan et al. BMC Hematology 2013, 13:7 Page 5 of 5
http://biomedcentral.com/2052-1839/13/7References
1. Bruckner AL, Frieden IJ: Hemangiomas of infancy. J Am Acad Dermatol
2003, 48(4):477–493.
2. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE:
Noninvoluting congenital hemangioma: a rare cutaneous vascular
anomaly. Plast Reconstr Surg 2001, 107(7):1647–1654.
3. Propp RP, Scharfman WB: Hemangioma-thrombocytopenia syndrome
associated with microangiopathic hemolytic anemia. Blood 1966,
28(5):623–633.
4. Baselga E, Cordisco MR, Garzon M, Lee MT, Alomar A, Blei F: Rapidly
involuting congenital haemangioma associated with transient
thrombocytopenia and coagulopathy: a case series. Br J Dermatol 2008,
158(6):1363–1370.
5. Lang PG, Dubin HV: Hemangioma-thrombocytopenia syndrome; a
disseminated intravascular coagulopathy. Arch Dermatol 1975, 111(1):105–107.
6. Sekhon SS, Roy V: Thrombocytopenia in adults: A practical approach to
evaluation and management. South Med J 2006, 99(5):491–498.
7. Stasi R, Willis F, Shannon MS, Gordon-Smith EC: Infectious causes of
chronic immune thrombocytopenia. Hematol Oncol Clin North Am 2009,
23(6):1275–1297.
8. Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT:
Hypersensitivity reaction and acute immune-mediated
thrombocytopenia from oxaliplatin: two case reports and a review of the
literature. J Hematol Oncol 2010, 3:12.
9. Namdev R, Dutta SR, Singh H: Acute immune thrombocytopenic purpura
triggered by insect bite. J Indian Soc Pedod Prev Dent 2009, 27(1):58–61.
10. Cines DB, Liebman HA: The immune thrombocytopenia syndrome: a
disorder of diverse pathogenesis and clinical presentation. Hematol Oncol
Clin North Am 2009, 23(6):1155–1161.
11. Cines DB, Liebman H, Stasi R: Pathobiology of secondary immune
thrombocytopenia. Semin Hematol 2009, 46(1 Suppl 2):S2–S14.
12. Stasi R: Immune thrombocytopenia: pathophysiologic and clinical
update. Semin Thromb Hemost 2012, 38(5):454–462.
13. Elsayes KM, Menias CO, Dillman JR, Platt JF, Willatt JM, Heiken JP: Vascular
malformation and hemangiomatosis syndromes: spectrum of imaging
manifestations. AJR Am J Roentgenol 2008, 190(5):1291–1299.
14. Mulliken JB, Enjolras O: Congenital hemangiomas and infantile
hemangioma: missing links. J Am Acad Dermatol 2004, 50(6):875–882.
15. Jin YB, Lin XX, Ma G, Chen H, Li W, Fan XD, Lin MS, Wang W, Zhou ZP:
Non-involuting congenital hemangioma: a study for diagnosis and
treatment. Zhonghua Zheng Xing Wai Ke Za Zhi 2009, 25(3):189–193.
16. Buckley MF, James JW, Brown DE, Whyte GS, Dean MG, Chesterman CN,
Donald JA: A novel approach to the assessment of variations in the
human platelet count. Thromb Haemost 2000, 83(3):480–484.
doi:10.1186/2052-1839-13-7
Cite this article as: Shivanthan et al.: Baseline thrombocytopenia
complicated by recurrent episodes of transient severe
thrombocytopenia following infections in an adult woman with a non
involuting congenital hemangioma – a case report. BMC Hematology
2013 13:7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
